research

BLOG – Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study

by

Key Findings To our knowledge this is the largest COVID-19 study to date with more than twenty-four million COVID-19 patients and twenty-six databases across three continents. This study provides essential context on the complications in unvaccinated subjects and shows a striking increase in risk of outcomes after COVID-19, like pulmonary embolism (x12), disseminated intravascular coagulation … Read more

DARWIN EU Open Call for Data Partners

by

DARWIN EU®, the Data Analysis and Real World Interrogation Network, has accomplished its first year of establishment. Following the set-up of the DARWIN EU® Coordination Centre in February 2022, the first ten Data Partners were onboarded. We are proud that multiple data sources included in this first year have been mapped to the OMOP CDM … Read more

Professor Peter Rijnbeek, EHDEN Coordinator, gives his inaugural lecture accepting his full professorship, highlighting with RWD/RWE, scale matters

by

EHDEN is extremely proud of our Coordinator, Prof Peter Rijnbeek, who gave his inaugural lecture to publicly accept his appointment as a full Professor of Medical Informatics, at Erasmus MC Faculty of Erasmus University Rotterdam on March 3rd. This is a delightful tradition in The Netherlands for a new Professor to outline his/her scientific view … Read more

EHDEN not-for-profit and Lundbeck collaborate on first research programme, in Neuroscience

by

Brussels, Belgium, 21st of February 2023:  The European Health Data and Evidence Network (EHDEN) and Lundbeck announce they have begun formative stages of neuroscience research with the EHDEN network and potential partners, including other Pharma companies. As an Innovative Medicines Initiative (IMI) project, EHDEN will reach end-of-its project phase in April 2024. To ensure EHDEN’s … Read more

Paper published in JAMIA Open journal on evaluating a novel approach to stimulate open science collaborations

by

The research process to analyse real world data that generates real world evidence is generally time-consuming, requiring considerable efforts and resources and planning over an extended period of time before its results can be shared, such as via publications. Meanwhile, patients, clinicians, and healthcare providers need evidence to support decision-making from individual treatment to populations … Read more

Uppsala Monitoring Centre/EHDEN pharmacovigilance evidence-a-thon

by

See also the accompanying article in Uppsala Reports here. The week of 5 September had more than thirty colleagues from the Uppsala Monitoring Centre (UMC), EHDEN, DARWIN EU, and EHDEN Data Partners come together in Uppsala, Sweden to take part in the UMC/EHDEN pharmacovigilance evidence-a-thon. The specific objective of this IMI EHDEN-sponsored event was to … Read more

EHDEN Research Coordinator receives ISPE Special Award for Epidemiology and Public Health

by

Brussels, Belgium, 5th September 2022: We are delighted to announce and celebrate the special award from the International Society of Pharmacoepidemiology (ISPE) for recognisable and impactful contributions to public health during the COVID-19 pandemic awarded to Prof Dani Prieto-Alhambra, EHDEN’s Research Coordinator, Professor of Pharmaco and Device Epidemiology, NDORMS, University of Oxford, and Professor, Real … Read more

BLOG – Reflections on the OHDSI Europe Symposium 2022

by

The OHDSI Europe Symposium 2022 (24-26 June) kicked off aboard the majestic transatlantic ship: the SS Rotterdam (moored permanently on the Meuse river in Rotterdam). It was a very anticipated and successful event in many respects, so I thought it would be worthwhile to reflect on what made this one so special. This was actually … Read more

BLOG – Real World Data’s Expanding Role in Conducting Research & Lessons Learned from COVID-19

by

My team and I are very pleased to see the COVID-19 virus waning thanks to vaccines (and mutations), and that we’re now in a much better place. However, it’s nevertheless still with us and there’s necessarily great interest in the long-term consequences of long COVID, i.e., infection/re-infection, infection with different variants, infection with people vaccinated, … Read more